Chopra I, Johnson S C, Bennett P M
J Antimicrob Chemother. 1987 Jun;19(6):743-51. doi: 10.1093/jac/19.6.743.
The possibility that chlorhexidine is a specific inhibitor of membrane bound bacterial adenosine triphosphatase (ATPase) was addressed. The in-vitro susceptibilities of several Providencia stuartii cell envelope enzymes, including ATPase, to chlorhexidine were compared. The following concentrations of chlorhexidine were required to cause 50% inhibition of enzyme activity in preparations from chlorhexidine-sensitive strains (MIC 50 mg chlorhexidine/l): ATPase (160 mg/l), succinic dehydrogenase (greater than 300 mg/l), penicillin binding protein 7 (300 mg/l) and beta-lactamase (45 mg/l). Fifty per cent inhibition of the ATPase from a chlorhexidine-resistant strain (MIC 1600 mg/l) was achieved at an in-vitro concentration of 225 mg chlorhexidine/l. Our observations do not support the suggestion that bacterial membrane-bound ATPases are specific targets for chlorhexidine.
研究了洗必泰是否为膜结合细菌腺苷三磷酸酶(ATP酶)的特异性抑制剂。比较了包括ATP酶在内的几种斯氏普罗威登斯菌细胞包膜酶对洗必泰的体外敏感性。对于洗必泰敏感菌株的制剂,引起50%酶活性抑制所需的洗必泰浓度如下(洗必泰最低抑菌浓度为50mg/l):ATP酶(160mg/l)、琥珀酸脱氢酶(大于300mg/l)、青霉素结合蛋白7(300mg/l)和β-内酰胺酶(45mg/l)。在体外洗必泰浓度为225mg/l时,可使一株洗必泰耐药菌株(最低抑菌浓度为1600mg/l)的ATP酶受到50%的抑制。我们的观察结果不支持细菌膜结合ATP酶是洗必泰特异性作用靶点这一观点。